Taribavirin
- Generic Name
- Taribavirin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C8H13N5O4
- CAS Number
- 119567-79-2
- Unique Ingredient Identifier
- R3B1994K2E
- Indication
Investigated for use/treatment in hepatitis (viral, C).
- Associated Conditions
- -
- Associated Therapies
- -
Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)
- First Posted Date
- 2007-03-12
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 278
- Registration Number
- NCT00446134
- Locations
- ๐บ๐ธ
Cedars-Sinai Medical Center, 8635 W. 3rd Street, Suite 590W, Los Angeles, California, United States
Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C
Phase 2
Terminated
- Conditions
- First Posted Date
- 2006-03-21
- Last Posted Date
- 2012-06-22
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT00305383
- Locations
- ๐บ๐ธ
Maryland Digestive Disease Research, Laurel, Maryland, United States
๐บ๐ธSan Mateo Medical Center, San Mateo, California, United States
๐บ๐ธLiver Center of Long Island, Plainview, New York, United States
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-10-03
- Last Posted Date
- 2012-06-22
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 900
- Registration Number
- NCT00230958
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive
Phase 3
Completed
- Conditions
- First Posted Date
- 2004-10-04
- Last Posted Date
- 2012-06-22
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 900
- Registration Number
- NCT00093093
- Locations
- ๐บ๐ธ
Cedars-Sinai Medical Center, Los Angeles, California, United States
๐จ๐ฆToronto Western Hospital, Toronto, Ontario, Canada
๐บ๐ธNorthwestern Memorial Hospital, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2024. All Rights Reserved by MedPath